SCHEMBL13727019

SCHEMBL13727019

Cc1cccc(Cl)c1C(=O)C(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ POLB P06746 2/20 0.46
▸ PDK1 Q15118 1/20 0.43
▸ PDK2 Q15119 1/20 0.43
▸ PDK3 Q15120 1/20 0.43
▸ PDK4 Q16654 1/20 0.43
▸ FABP3 P05413 1/20 0.41
▸ FABP4 P15090 1/20 0.41
▸ UTS2R Q9UKP6 1/20 0.38
▸ HCRTR1 O43613 1/20 0.38
▸ HCRTR2 O43614 1/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ FEN1 P39748 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ ITGB1 P05556 2/20 0.37
▸ ITGA4 P13612 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13028740 0.88 ALDH1A1 (0.54) TYK2ALDH1A1POLBPDK1PDK2
SCHEMBL13151930 0.86 L3MBTL1 (0.41) TYK2ALDH1A1RAB9A
SCHEMBL13543212 0.79 GAA (0.54) TYK2ALDH1A1POLBRAB9AKMT2A
SCHEMBL476833 0.78 ALDH1A1 (0.71) TYK2ALDH1A1PDK1PDK2PDK3
SCHEMBL484445 0.78 FABP3 (0.55) TYK2ALDH1A1FABP3FABP4FEN1
SCHEMBL13100052 0.78 ALDH1A1 (0.52) TYK2ALDH1A1PDK1PDK2PDK3
SCHEMBL30676249 0.78 FABP3 (0.55) TYK2ALDH1A1FABP3FABP4FEN1
SCHEMBL26054598 0.77 CES2 (0.48) RAB9AKMT2AGAAMAPTNPSR1
SCHEMBL18671762 0.77 TYK2 (0.51) TYK2ALDH1A1POLBPDK1PDK2
SCHEMBL4919855 0.77 TYK2 (0.55) TYK2ALDH1A1POLBPDK1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884043-B2 RORgammaT inhibitors MERCK SHARP & DOHME CORP. (US) 2018-02-06 — — US disclosed
US-9884043-B2 RORgammaT inhibitors MERCK SHARP & DOHME CORP. (US) 2018-02-06 — — US disclosed
US-20180022701-A1 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF MERCK SHARP & DOHME LLC 2018-01-25 — — US disclosed
US-20170340610-A1 RORgammaT INHIBITORS MERCK SHARP & DOHME LLC 2017-11-30 — — US disclosed
US-20170340610-A1 RORgammaT INHIBITORS MERCK SHARP & DOHME LLC 2017-11-30 — — US disclosed
US-9745265-B2 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof MERCK SHARP & DOHME CORP. (US) 2017-08-29 — — US disclosed
US-9603838-B2 RORgammaT inhibitors MERCK SHARP & DOHME CORP. (US) 2017-03-28 — — US disclosed
US-20150297566-A1 RORgammaT INHIBITORS MERCK SHARP & DOHME LLC 2015-10-22 — — US disclosed
US-20150218096-A1 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF MERCK SHARP & DOHME LLC 2015-08-06 — — US disclosed
US-9095583-B2 RORgammaT inhibitors MERCK SHARP & DOHME CORP. (US) 2015-08-04 — — US disclosed
US-20140038942-A1 RORgammaT INHIBITORS MERCK SHARP & DOHME B.V. (NL) 2014-02-06 — — US disclosed
US-20090203663-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2009-08-13 — — US disclosed
US-20090137601-A1 L-Phenylalanine Derivatives ASTRAZENECA AB (SE) 2009-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203663-A1 CHEMICAL COMPOUNDS ITGB5, ITGB1, ITGA2B TYK2 4559/4885ALDH1A1 565/4885POLB 1757/4885
US-20150297566-A1 RORgammaT INHIBITORS RORB, RORC, RORA TYK2 527/4885ALDH1A1 1003/4885POLB 3307/4885
US-20170340610-A1 RORgammaT INHIBITORS RORB, RORC, RORA TYK2 543/4885ALDH1A1 858/4885POLB 3551/4885
US-20180022701-A1 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF RORB, RORA, RORC TYK2 948/4885ALDH1A1 263/4885POLB 2997/4885
US-20090137601-A1 L-Phenylalanine Derivatives ITGB5, ITGB1, ITGA2B TYK2 2616/4885ALDH1A1 1156/4885POLB 2138/4885
US-20140038942-A1 RORgammaT INHIBITORS RORB, RORC, RORA TYK2 543/4885ALDH1A1 858/4885POLB 3551/4885
US-20150218096-A1 4-HETEROARYL SUBSTITUTED BENZOIC ACID COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF RORB, RORA, RORC TYK2 948/4885ALDH1A1 263/4885POLB 2997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback